Endotoxin Activity Assay-guided Polymyxin B Hemoperfusion: From Failed Trials to Biological Enrichment

Ricard Ferrer, Koki Namekawa, Shunichiro Urabe, Hiroshi Mukaida, Nao Umei, Toshiaki Iba · 2026

Read Endotoxin Activity Assay-guided Polymyxin B Hemoperfusion: From Failed Trials to Biological Enrichment by Ricard Ferrer, Koki Namekawa, Shunichiro Urabe, Hiroshi Mukaida, Nao Umei, Toshiaki Iba (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7166510838.txt.

Description

Ricard Ferrer, an intensive care specialist in Barcelona, led a 2026 review with Juntendo University co-authors on filtering endotoxin from the blood of patients in septic shock. The treatment, polymyxin B hemoperfusion, passes blood through a cartridge that adsorbs endotoxin, a bacterial toxin that drives organ failure. Early small trials encouraged use, but larger randomized trials without patient selection came back neutral.

A newer trial selected patients whose endotoxin activity assay fell in a defined mid-range and who had high organ dysfunction. In that group, treatment was linked to a high probability of reduced mortality, mainly at ninety days. The authors argue for this biologically enriched selection, while flagging doubts about the assay's results, feasibility, and reach.

Catalog record

CREATORRicard Ferrer, Koki Namekawa, Shunichiro Urabe, Hiroshi Mukaida, Nao Umei, Toshiaki Iba
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / Juntendō Igaku/Juntendo igaku

Source: https://doi.org/10.14789/ejmj.jmj26-0042-r

Browse the full library · About the Tower of Babel